RecruitingEarly Phase 1NCT05377216
Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation
Sponsor
University of Pennsylvania
Enrollment
20 participants
Start Date
Sep 1, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
Prospective cohort study evaluating the electrophysiologic and biochemical effects of stellate ganglion block in patients with ventricular tachycardia.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Planned catheter based VT ablation
- Age at least 18 years
Exclusion Criteria4
- Pregnancy
- Contraindication to SGB or VT ablation
- Hypersensitivity of local anesthetic of amide type
- Hemodynamic instability during the procedure prior to the study protocol
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGStellate Ganglion Block
Left sided percutaneous stellate ganglion block
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05377216
Related Trials
Real-Time Intracardiac Echocardiography for Ventricular Arrhythmia Ablation
NCT072015062 locations
Venous Ethanol for Ventricular Tachycardia
NCT055112461 location
DEEP Substrate Mapping Versus Activation Mapping for VT
NCT063717291 location
Coronary Flow During Rapid Heart Rates
NCT058411991 location
Peri-Procedural Transmural Electrophysiological (EP) Imaging of Scar-Related Ventricular Tachycardia
NCT037138661 location